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Intestinal differentiation in the endometrium is rare with only case reports in the international literature. We
describe a case of simultaneous endocervical and intestinal-type mucinous differentiation with goblet cells arising
in a FIGO grade 1 endometrioid adenocarcinoma. The patient had no involvement of the myometrium, cervix, or
extra-uterine sites. There were no intestinal metaplastic changes of the endocervical canal. The etiology of this
change is unknown, although recent reports suggest an association with hyperestrogenism.
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Endocervical-type mucinous differentiation in endome-
trioid adenocarcinoma is not uncommon. However, in-
testinal differentiation in the endometrium is rare with
only case reports in the international literature. These
included two cases associated with endometrial carcinoma
where the intestinal differentiation was uncovered upon
application of special stains [1] and two cases associated
with an endometrial polyp and endometrial hyperplasia
[2]. Reports of rare carcinoma of the endometrium,
their immunohistocheamical staining patterns and
tissue reaction to endometrial carcinoma are available
in the literature [3-5]. We present a case of simultaneous
intestinal differentiation with goblet cells and endocervical-
type mucinous differentiation in a FIGO grade 1 endo-
metrioid adenocarcinoma.
Case presentation
The patient is a 55 year old gravida 2, para 2 with a chief
complaint of postmenopausal bleeding. Her past medical* Correspondence: mquddus@wihri.org
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distribution, and reproduction in any mediumhistory is significant for morbid obesity (BMI 40), type II
diabetes, hypertension, and asthma. CT scan showed het-
erogeneity of the uterus and bilateral hydrosalpinx, with
no evidence of metastatic disease. The patient underwent
an endometrial biopsy and a subsequent robotic assisted
total laparoscopic hysterectomy and bilateral salpingo-
oophorectomy. The post-surgical course was unremark-
able and the patient was discharged on post-op day 3.Pathological findings
Endometrial biopsy revealed a well differentiated endome-
trioid adenocarcinoma, FIGO grade 1, arising in a back-
ground of complex atypical hyperplasia. On hysterectomy,
the uterus measured 6.0 × 5.5 × 4.5 cm uterus with a
smooth glistening serosal surface and an attached cervix.
The specimen was opened to reveal a 1.5 × 1.5 cm intra-
uterine mass occupying the posterior aspect of the uterine
fundus. The remainder of the 3.9 × 3.8 cm endometrium
was pink-tan. The myometrium was grossly uninvolved by
tumor. The endocervical canal was unremarkable. Bilateral
adnexae consisted of white bosselated ovaries and previ-
ously ligated fallopian tube with fimbriated ends. The
endometrium was submitted in its entirety.entral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
Figure 1 Endometrioid adenocarcinoma with endocervical (A) and intestinal type (B) mucinous differentiation. Classic endometrioid
adenocarcinoma is seen in the left side of panel B adjacent to the intestinal-type metaplasia. AB-PAS highlights goblet cells with deep blue
staining (C). CDX-2 is positive in the intestinal type cells (D).
Table 1 Immunohistochemical profile of intestinal
metaplasia in G1 EMCA
Antibody Antibody information Results
Cytokeratin 7 M; OV-TL 12/30; Dako Positive
Cytokeratin 20 M; Ks20.8; Dako Negative
CDX2 M; DAK-CDX-2; Dako Focally positive
Carcinoembryonic Antigen
(CEA)
M; II-7; Dako Focally positive
Synaptophysin M; SY38; Dako Negative
Chromogranin P; Rabbit; Dako Negative
M: Monoclonal, P: Polyclonal.
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http://www.diagnosticpathology.org/content/8/1/128Microscopically, the tumor consisted primarily of an
endometrioid adenocarcinoma of usual type which fo-
cally showed endocervical-type mucinous differentiation
(Figure 1A). Endocervical-type mucinous differentiation
is characterized by tall columnar mucin filled cells with
basally located nuclei. Two adjacent microscopic foci
also showed readily visible intestinal-type mucinous dif-
ferentiation with basally located hyperchromatic nuclei
and goblet cells (Figure 1B). There was involvement of
superficial adenomyosis by tumor, but no true myometrial
invasion. As in the prior biopsy, a background of complex
atypical endometrial hyperplasia was noted. The lower
uterine segment and cervix were free of tumor and so was
lymph-vascular invasion. No intestinal-type metaplastic
change was noted in the endocervical canal. Bilateral fallo-
pian tubes showed only benign changes and a small serous
adenofibroma was discovered in the left ovary.
Special stains and immunohistochemical (IHC) ana-
lysis was employed to further characterize the cells of
interest. Alcian blue-perioidic acid-schiff stain (AB-PAS)
stains acid mucins such as those in goblet cells blue
while the neutral mucins of endocervical-type cells are
pink as in the classic PAS stain. AB-PAS stain in this
case confirms the morphologic impression of goblet cells
by staining the acid mucin a deep blue color while the
endocervical-type mucinous cells show faint pink stain-
ing (Figure 1C). IHC of the areas with intestinal differen-
tiation revealed Cytokeratin (CK) 7 positivity, while CK20was negative. CDX2 (Figure 1D) and CEA were focally
positive in the cells of interest, while synaptophysin and
chromogranin were completely negative (Table 1).
Discussion and conclusions
Mucinous differentiation in endometrioid adenocarcin-
omas is not uncommon and pure mucinous adenocar-
cinomas of the endometrium comprise 1-10% of all
endometrioid adenocarcinomas. Most mucin producing
tumors of the endometrium are well differentiated with
endocervical-type mucin producing cells characterized
by tall columnar cells with basally located nuclei. However,
the presence of intestinal differentiation, and of goblet cells
in particular, within the endometrium is rare. The largest
series of endometrial goblet cells differentiation in the
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tified with the assistance of special stains [1]. Two cases
of intestinal metaplasia, one in an endometrial polyp and
one in association with complex hyperplasia without
atypia, have recently been reported [2]. Neither was asso-
ciated with endometrial carcinoma, in contrasts to ours.
One was associated with concurrent intestinal metaplasia
of the endocervical canal. Two cases of endometrial
adenocarcinomas with signet ring cells have been reported
in the literature [6] and an additional case of mucinous
adenocarcinoma of the endometrium was found to have a
gastric phenotype on immunohistochemistry mimicking a
minimal deviation adenocarcinoma of the cervix [7]. As in
this case, all were associated with more typical appearing
endometrioid adenocarcinoma. Enteric-type mucin has
been identified in endometrial adenocarcinomas, a finding
which verifies the ability of the Mullerian epithelium to
undergo metaplasia along an intestinal lineage [8]. No
cases in that series, however, showed morphologic intes-
tinal differentiation and there was no correlation with
tumor grade.
The presence of goblet cell within the endometrium
raises the legitimate question for metastasis. Bland well-
differentiated intestinal-type mucinous epithelium with
goblet cell in the endometrium, endocervix, and fallo-
pian tubes, has been shown to be metastatic lesions from
gastrointestinal primaries [9]. Clinical evaluation for
an occult primary gastrointestinal lesion as well as careful
gross and histologic exam is necessary. Cytokeratins are
useful in this setting as metaplastic Mullerian epithelium
retains CK7 positivity, as in our case. In this current case,
the patient had no clinical gastrointestinal lesion. The
gross exam was that of a classic non-invasive carcin-
oma arising from endometrial. No involvement of the
adnexa, serosa, or the myometrium by the tumor was
noted and the cells with intestinal differentiation were
intimately associated and readily visible with the endo-
metrioid carcinoma.
Intestinal-type metaplasia is more common within the
endocervix, with reports of cases in non-neoplastic and
endocervical adenocarcinoma [1,10]. Intestinal metapla-
sia in the endocervix is associated with both adenocarcin-
oma in-situ and endocervical adenocarcinoma and the
presence of intestinal-type cells on cervical biopsy war-
rants further workup.
The etiology of intestinal-type differentiation within
the endometrium is unclear. The two recently reported
cases associated with non-neoplastic lesions were as-
sociated with probable hyperestrogenism [2], a find-
ing replicated in this patient who was obese and had
a background of endometrial hyperplasia. This is in
contrast to the proposed mechanism of endocervical-type
mucinous metaplasia which has been linked to use of tam-
oxifen and exogenous progestin [11,12].With the addition of our case, the number of cases of
intestinal-type differentiation with goblet cells in the
endometrium is increased to five, with two cases being
benign and two cases associated with adenocarcinoma
only detected with special stains [1,2]. This entity is ex-
tremely rare, this being the first case encountered in our
sub-specialty practice and consult service.
The clinical implication of finding intestinal-type dif-
ferentiation in endometrial carcinoma, as in our case
report, remains in the fact that the pathologists and cli-
nicians needed to be aware that such differentiation may
occur in primary endometrial carcinoma and that the
finding of intestinal-type mucinous differentiation in
endometrial carcinoma should also warrant careful clinico-
pathologic work-up to exclude a metastatic carcinoma
from the gastro-intestinal tract.
Consent
The patient has given written consent for the use of the
images and case presentation for educational and scien-
tific purposes provided the unique personal identifica-
tion is not revealed.
Competing interests
The authors declare no competing financial interest. All the authors have
actively participated in the diagnosis process or manuscript writing.
Authors’ contributions
RBG is the Stuart Lauchlan Fellow in Gynecologic and Breast Pathology and
has written up the case report and MRQ is the attending Pathologist on the
case. CJS and WDL were involved in interpreting the special stains. All
authors read and approved the final manuscript.
Received: 28 February 2013 Accepted: 21 June 2013
Published: 2 August 2013
References
1. Nieuwenhuizen L, Khalil MK, Naik VR, Othman NH: Prevalence of goblet
cell metaplasia in endocervical and endometrial adenocarcinoma: a
histochemical study. Malays J Med Sci 2007, 14:56–61.
2. Nicolae A, Goyenaga P, McCluggage WG, Preda O, Nogales FF: Endometrial
intestinal metaplasia: a report of two cases, including one associated
with cervical intestinal and pyloric metaplasia. Int J Gynecol Pathol 2011,
30:492–496.
3. Yasuda M, Katoh T, Hori S, et al: Endometrial intraepithelial carcinoma in
association with polyp: review of eight cases. Diagn Pathol 2013, 8:25.
4. Ribeiro-Silva A: Immunohistohemical features of a papillary squamous
cell carcinoma of the endomertrium with transitional cell differentiation.
Diagn Pathol 2007, 2:26.
5. Uehara K, Yasuda M, Ichimura T, et al: Peritoneal granuloma associated
with endometrial adenocarcinoma of the uterine corpus. Diagn Pathol
2011, 6:106.
6. Boyd C, Cameron I, McCluggage WG: Endometrial adenocarcinoma with
signet ring cells: report of two cases of an extremely rare phenomenon.
Int J Gynecol Pathol 2010, 29:579–582.
7. Abiko K, Baba T, Ogawa M, Mikami Y, Koyama T, Mandai M, Konishi I: Minimal
deviation mucinous adenocarcinoma (‘adenoma malignum’) of the uterine
corpus. Pathol Int 2010, 60:42–47.
8. McCluggage WG, Roberts N, Bharucha H: Enteric differentiation in
endometrial adenocarcinomas: a mucin histochemical study. Int J Gynecol
Pathol 1995, 14:250–254.
9. Moore WF, Bentley RC, Kim KR, Olatidoye B, Gray SR, Robboy SJ: Goblet-cell
mucinous epithelium lining the endometrium and endocervix: evidence
Buell-Gutbrod et al. Diagnostic Pathology 2013, 8:128 Page 4 of 4
http://www.diagnosticpathology.org/content/8/1/128of metastasis from an appendiceal primary tumor through the use of
cytokeratin-7 and −20 immunostains. Int J Gynecol Pathol 1998, 17:363–367.
10. Park KJ, Bramlage MP, Ellenson LH, Pirog EC: Immunoprofile of
adenocarcinomas of the endometrium, endocervix, and ovary with
mucinous differentiation. Appl Immunohistochem Mol Morphol 2009, 17:8–11.
11. Clement PB, Young RH: Endometrioid carcinoma of the uterine corpus: a
review of its pathology with emphasis on recent advances and
problematic aspects. Adv Anat Pathol 2002, 9:145–184.
12. Dallenbach-Hellweg G, Hahn U: Mucinous and clear cell adenocarcinomas
of the endometrium in patients receiving antiestrogens (tamoxifen) and
gestagens. Am J Pathol 1995, 14:7–15.
doi:10.1186/1746-1596-8-128
Cite this article as: Buell-Gutbrod et al.: Endometrioid adenocarcinoma
with simultaneous endocervical and intestinal-type mucinous
differentiation: report of a rare phenomenon and the
immunohistochemical profile. Diagnostic Pathology 2013 8:128.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
